Trial Profile

Randomised phase II trial of bevacizumab (AVASTIN) in combination with gemcitabine or attenuated doses of cisplatin and gemcitabine as first-line treatment of elderly patients with advanced non-squamous non-small cell lung cancer - EAGLES

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 09 Oct 2017

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

14 Jul 2014 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
23 Jun 2014 Planned End Date changed from 1 Apr 2014 to 1 Jun 2014 as per ClinicalTrials.gov record.
23 Jun 2014 Planned primary completion date changed from 1 Apr 2014 to 1 Jun 2014 as per ClinicalTrials.gov record.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com